EGFR and non-small cell lung carcinoma: Therefore, EGFR is considered an important target of multiple cancer therapies, including non-small cell lung carcinoma (NSCLC), head and neck squamous cell cancers (HNSCCs), glioblastoma, and breast, esophageal, colon, colorectal, anal, lung, gastric, bladder, endometrial, melanoma, prostate, pancreatic and ovarian cancers.